# Radioimmunoimaging of AL Amyloidosis

> **NCT00807872** · PHASE1 · COMPLETED · sponsor: **University of Tennessee** · enrollment: 40 (actual)

## Conditions studied

- Primary Amyloidosis

## Interventions

- **BIOLOGICAL:** 124I-labeled monoclonal antibody Mu 11-1F4

## Key facts

- **NCT ID:** NCT00807872
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-03
- **Final completion:** 2013-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807872, "Radioimmunoimaging of AL Amyloidosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00807872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*